AMTX

SEC source: 0001593968-21-000714 · primary_01.xml · derivative · entry 2

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2028-01-18

F1 · price: The 1-18-2018 option grant was exercised and sold through 10b5-1 plan sold.

SEC source: 0001593968-21-002151 · primary_01.xml · nonDerivative · entry 5

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · kind: 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · shares: The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 1/18/2018 grant.

SEC source: 0001593968-21-000714 · primary_01.xml · derivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common stock and Series B Preferred · 20,000 shares

Expires 2028-01-18

F1 · price: The 1-18-2018 option grant was exercised and sold through 10b5-1 plan sold.

SEC source: 0001593968-21-002151 · primary_01.xml · nonDerivative · entry 4

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · kind: 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · shares: The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 1/18/2018 grant.

SEC source: 0001593968-21-000643 · primary_01.xml · derivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock and Series B Preferred · 20,000 shares

Expires 2028-01-18

F1 · price: The 1-18-2018 option grant was exercised and sold through 10b5-1 plan sold.

SEC source: 0001593968-21-002151 · primary_01.xml · nonDerivative · entry 3

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · kind: 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · shares: The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 1/18/2018 grant.

SEC source: 0001593968-21-000573 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2027-01-19

F1 · price: The 1-19-2017 option grant was exercised and sold through 10b5-1 plan sold as below

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 18

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000536 · primary_01.xml · derivative · entry 3

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2027-01-19

F1 · price: The 1-19-2017 option grant was exercised and sold through 10b5-1 plan sold as below

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 17

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000536 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2027-01-19

F1 · price: The 1-19-2017 option grant was exercised and sold through 10b5-1 plan sold as below

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 16

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000536 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2027-01-19

F1 · price: The 1-19-2017 option grant was exercised and sold through 10b5-1 plan sold as below

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 15

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000499 · primary_01.xml · derivative · entry 2

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2028-01-18

F2 · price: The 1-18-2018 option grant was exercised and sold through 10b5-1 plan sold.

SEC source: 0001593968-21-000499 · primary_01.xml · derivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2027-11-16

F1 · price: The 11-16-2017 option grant was exercised and sold through 10b5-1 plan sold as below

SEC source: 0001593968-21-000498 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002151 · primary_01.xml · nonDerivative · entry 2

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · kind: 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · shares: The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 11/16/2017 grant.

SEC source: 0001593968-21-002151 · primary_01.xml · nonDerivative · entry 1

BARTON FRANCIS P · CIK 0001236181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,452

F1 · kind: 1.These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · shares: The Reporting person sold the 10000 shares acquired on sale date through by paying cash for the option cost of the 1/18/2018 grant.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 14

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000498 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 13

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000408 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 12

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000408 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 11

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000383 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 10

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000384 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F1 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-000383 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 15

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 9

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000359 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-000358 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F1 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 14

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 8

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000359 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-000358 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F1 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 13

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 7

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000345 · primary_01.xml · derivative · entry 2

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-000344 · primary_01.xml · derivative · entry 3

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2023-05-17

F2 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 12

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 6

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.

SEC source: 0001593968-21-000345 · primary_01.xml · derivative · entry 1

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common stock and Series B Preferred · 10,000 shares

Expires 2026-05-21

F1 · price: The 10,000 shares were exercised from grant 5/19/2016 and sold through executing the 10b5-1 plan.

F2 · derivative.exercise_date: 1/12th of the Option Shares vest every three(3)months from the date of the grant.

SEC source: 0001593968-21-000344 · primary_01.xml · derivative · entry 2

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common stock and Series B Preferred · 5,000 shares

Expires 2023-05-17

F2 · price: The 10,000 shares were exercised from grant 5/17/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-000344 · primary_01.xml · derivative · entry 1

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common stock and Series B Preferred · 5,000 shares

Expires 2028-01-18

F1 · price: The 10,000 shares were exercised from grant 1/18/2018 and sold through executing the 10b5-1 plan.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 11

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002287 · primary_01.xml · nonDerivative · entry 9

FOSTER ANDREW B · CIK 0001285221 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,235

F3 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F2 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 5,235 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, April 19, April 22, 2021 option exercises in which the Reporting Person sold all but 176,3134,3 shares respectively received upon exercise, the above total beneficially owned 8,548 shares were sold on 9/15/2021 and filed on Form 4 appropriately. As of the date of this filing, the Reporting Person did not own any beneficial shares of the Issuers common stock.

SEC source: 0001593968-21-002312 · primary_01.xml · nonDerivative · entry 5

Waltz Todd · CIK 0001383895 · Executive Vice President, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 165,401

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 plan.

F1 · kind: These transactions were incorrectly reported in Table II on prior Form 4s filed by the Reporting Person in connection with the Reporting Persons exercise of stock options and sale of common stock from those issuances.

F3 · balance_after: As of the date of the first reported transaction on this Form 4, the Reporting Person beneficially owned 165,401 shares of the Issuers common stock. Each of the sale and withholding transactions reported herein was with respect to shares received from the exercise of stock options previously described on prior Form 4s. Except in connection with the March 17, 2021 option exercise in which the Reporting Person sold all but 2,539 shares received upon exercise, the transactions reported herein did not result in a net change in the number of shares beneficially owned by the Reporting Person. As of the date of this filing, the Reporting Person beneficially owned 167,940 shares of the Issuers common stock.